Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 07 Jun 2024 22:32:59 +0200Tue, 28 May 2024 16:11:00 +0200Sarclisa : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4977-en_1.pdfSarclisa : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4977-en_1.pdfTue, 28 May 2024 16:11:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/sarclisaHuman medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/sarclisaTue, 28 May 2024 14:50:00 +0200Human medicine